Please provide your email address to receive an email when new articles are posted on . A universal model predicted CV events for people with and without baseline atherosclerotic CVD. Some patients ...

It’s a good question. Interesting how the answer continues to be absent from business school curriculums! In 1993, being convinced that good safety programs produced marginal results at best, I joined ...

French artificial intelligence startup Bioptomus, pioneers of the biology research model family H-Optomus, today announced the availability of the company’s next-gen clinical biology AI model, ...

Developed by researchers at Johns Hopkins Bloomberg School of Public Health, the model could change how doctors worldwide assess patients' chances for heart attacks, strokes, and other cardiac events ...

French artificial intelligence startup Bioptimus, pioneers of the biology research model family H-Optomus, today announced the availability of the company’s next-gen clinical biology AI model, ...